Kudos to NP for getting us to this point, but this point is not good enough to guarantee success despite a potentially once in a generation drug. Until approval of this drug for something, and/ or financing is in place, this is still a speculative play, not an investment . Many industries have specialists: baseball has closers; football has field goal kickers and on and on. Perhaps NP, the street fighter and his particular set of skills were good enough to get us here, but are not what is needed for the next level.
The next CC will drive the SP to the next lower level unless Specific accomplishments are actually announced like financing, uplisting full enrollment of a trial or even knowing[color=red][/color] the EXACT amount of people in every trial. If there are only 8 or 10 people in a trial how can the top executives not know the exact numbers? It may seem trivial to some, but each little gaff is magnified because they are numerous and more people are watching. If as some say FDA and big pharma are conspiring against CYDY don’t we need our best performance at every turn?
Np didn’t guarantee the financing but someone else told me it was guaranteed and I did not see that announcement today... we were told it would be done end of week. It would be better to just say we are working on it than miss another benchmark. Self inflicted error. Better to say nothing.
Also announcing a prospective article about leronlimab in publication caused the publication to decline the article... this was not his finest moment.
NP please do not have another call unless you have something specific to say.
